Janina Krell-Roesch1, Anna Pink1, Rosebud O Roberts2,3, Gorazd B Stokin4, Michelle M Mielke2, Kathleen A Spangehl1, Mairead M Bartley3, David S Knopman3, Teresa J H Christianson5, Ronald C Petersen2,3, Yonas E Geda1,2,6,7. 1. Translational Neuroscience and Aging Program, Mayo Clinic, Scottsdale, Arizona. 2. Division of Epidemiology, Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota. 3. Department of Neurology, Mayo Clinic, Rochester, Minnesota. 4. International Clinical Research Center, Brno, Czech Republic. 5. Division of Biomedical Statistics and Informatics, Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota. 6. Department of Psychiatry and Psychology, Mayo Clinic, Scottsdale, Arizona. 7. Department of Neurology, Mayo Clinic, Scottsdale, Arizona.
Abstract
OBJECTIVES: To investigate the timing (mid- vs late life) of physical activity, apolipoprotein (APO)E ε4, and risk of incident mild cognitive impairment (MCI). DESIGN: Prospective cohort study. SETTING: Mayo Clinic Study of Aging (Olmsted County, MN). PARTICIPANTS: Cognitively normal elderly adults (N = 1,830, median age 78, 50.2% female). MEASUREMENTS: Light, moderate, and vigorous physical activities in mid- and late life were assessed using a validated questionnaire. An expert consensus panel measured MCI based on published criteria. Cox proportional hazards models were used to calculate hazard ratios (HRs) and 95% confidence intervals (CIs) with age as a time scale after adjusting for sex, education, medical comorbidity, and depression. RESULTS: Light (HR = 0.58, 95% CI = 0.43-0.79) and vigorous (HR = 0.78, 95% CI = 0.63-0.97) physical activity in midlife were associated with lower risk of incident MCI. The association between moderate activity and incident MCI was not significant (HR = 0.85, 95% CI = 0.67-1.09). In late life, light (HR = 0.75, 95% CI = 0.58-0.97) and moderate (HR = 0.81, 95% CI = 0.66-0.99) but not vigorous physical activity were associated with lower risk of incident MCI. A synergistic interaction was also observed between mid- and late-life activity in reducing risk of incident MCI. Furthermore, APOE ε4 carriers who did not exercise had a higher risk of incident MCI than noncarriers who reported physical activity. CONCLUSION: Physical activity reduced the risk of incident MCI. Exercising in mid- and late life had an additive synergistic interaction in reducing the risk of MCI.
OBJECTIVES: To investigate the timing (mid- vs late life) of physical activity, apolipoprotein (APO)E ε4, and risk of incident mild cognitive impairment (MCI). DESIGN: Prospective cohort study. SETTING:Mayo Clinic Study of Aging (Olmsted County, MN). PARTICIPANTS: Cognitively normal elderly adults (N = 1,830, median age 78, 50.2% female). MEASUREMENTS: Light, moderate, and vigorous physical activities in mid- and late life were assessed using a validated questionnaire. An expert consensus panel measured MCI based on published criteria. Cox proportional hazards models were used to calculate hazard ratios (HRs) and 95% confidence intervals (CIs) with age as a time scale after adjusting for sex, education, medical comorbidity, and depression. RESULTS: Light (HR = 0.58, 95% CI = 0.43-0.79) and vigorous (HR = 0.78, 95% CI = 0.63-0.97) physical activity in midlife were associated with lower risk of incident MCI. The association between moderate activity and incident MCI was not significant (HR = 0.85, 95% CI = 0.67-1.09). In late life, light (HR = 0.75, 95% CI = 0.58-0.97) and moderate (HR = 0.81, 95% CI = 0.66-0.99) but not vigorous physical activity were associated with lower risk of incident MCI. A synergistic interaction was also observed between mid- and late-life activity in reducing risk of incident MCI. Furthermore, APOE ε4 carriers who did not exercise had a higher risk of incident MCI than noncarriers who reported physical activity. CONCLUSION: Physical activity reduced the risk of incident MCI. Exercising in mid- and late life had an additive synergistic interaction in reducing the risk of MCI.
Authors: R O Roberts; Y E Geda; D S Knopman; R H Cha; V S Pankratz; B F Boeve; E G Tangalos; R J Ivnik; W A Rocca; R C Petersen Journal: Neurology Date: 2012-01-25 Impact factor: 9.910
Authors: Sean P Deeny; David Poeppel; Jo B Zimmerman; Stephen M Roth; Josef Brandauer; Sarah Witkowski; Joseph W Hearn; Andrew T Ludlow; José L Contreras-Vidal; Jason Brandt; Bradley D Hatfield Journal: Biol Psychol Date: 2008-03-02 Impact factor: 3.251
Authors: Denise Head; Julie M Bugg; Alison M Goate; Anne M Fagan; Mark A Mintun; Tammie Benzinger; David M Holtzman; John C Morris Journal: Arch Neurol Date: 2012-05
Authors: Jennifer L St Sauver; Brandon R Grossardt; Barbara P Yawn; L Joseph Melton; Walter A Rocca Journal: Am J Epidemiol Date: 2011-03-23 Impact factor: 4.897
Authors: Oscar L Lopez; William J Jagust; Steven T DeKosky; James T Becker; Annette Fitzpatrick; Corinne Dulberg; John Breitner; Constantine Lyketsos; Beverly Jones; Claudia Kawas; Michelle Carlson; Lewis H Kuller Journal: Arch Neurol Date: 2003-10
Authors: J Carson Smith; Melissa A Lancaster; Kristy A Nielson; John L Woodard; Michael Seidenberg; Sally Durgerian; Ken Sakaie; Stephen M Rao Journal: Neuroimage Date: 2015-08-08 Impact factor: 6.556
Authors: Janina Krell-Roesch; Nathanael T Feder; Rosebud O Roberts; Michelle M Mielke; Teresa J Christianson; David S Knopman; Ronald C Petersen; Yonas E Geda Journal: J Alzheimers Dis Date: 2018 Impact factor: 4.472
Authors: Cara L Berkowitz; Lisa Mosconi; Olivia Scheyer; Aneela Rahman; Hollie Hristov; Richard S Isaacson Journal: Healthcare (Basel) Date: 2018-07-13
Authors: Janina Krell-Roesch; Jeremy A Syrjanen; Maria Vassilaki; Bettina Barisch-Fritz; Sandra Trautwein; Klaus Boes; Alexander Woll; Walter K Kremers; Mary M Machulda; Michelle M Mielke; David S Knopman; Ronald C Petersen; Yonas E Geda Journal: Eur J Ageing Date: 2019-04-12
Authors: Janina Krell-Roesch; Jeremy A Syrjanen; Jelena Bezold; Sandra Trautwein; Bettina Barisch-Fritz; Klaus Boes; Alexander Woll; Erica Forzani; Walter K Kremers; Mary M Machulda; Michelle M Mielke; David S Knopman; Ronald C Petersen; Maria Vassilaki; Yonas E Geda Journal: J Alzheimers Dis Date: 2021 Impact factor: 4.160